High-dose cytarabine in acute myeloid leukemia treatment: a systematic review and meta-analysis.

The optimal dose, scheme, and clinical setting for Ara-C in acute myeloid leukemia (AML) treatment remain uncertain. In this study, we performed a meta-analysis to systematically assess the impact of high-dose cytarabine (HDAC) on AML therapy during the induction and consolidation stages. Twenty-two...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Wei Li, Xiaoyuan Gong, Mingyuan Sun, Xingli Zhao, Benfa Gong, Hui Wei, Yingchang Mi, Jianxiang Wang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2014-01-01
Colecção:	PLoS ONE
Acesso em linha:	http://europepmc.org/articles/PMC4192550?pdf=render
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!